Disinfecting dystonia? Drug discovery using worms identifies an antibiotic as a neuroprotective lead molecule for movement disorders

Author： Caldwell Guy A   Caldwell Kim A  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.5, Iss.4, 2010-07, pp. : 473-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disorder of movement preparation in dystonia

By Hallett M.  

Brain, Vol. 123, Iss. 9, 2000-09 ,pp. : 1765-1766

Oxford University Press

Access to resources Recommend Favorite

Validation of the Neuroinflammation Cycle as a Drug Discovery Target Using Integrative Chemical Biology and Lead Compound Development with an Alzheimer's Disease-Related Mouse Model

By  

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 197-205

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategies

By Janero David   Vadivel Subramanian   Makriyannis Alexandros  

International Review of Psychiatry, Vol. 21, Iss. 2, 2009-04 ,pp. : 122-133

Informa Healthcare

Access to resources Recommend Favorite

De Novo and Molecular Target-Independent Discovery of Orally Bioavailable Lead Compounds for Neurological Disorders

By  

Current Alzheimer Research, Vol. 3, Iss. 3, 2006-07 ,pp. : 205-214

Bentham Science Publishers

Access to resources Recommend Favorite

Psychiatric disorders in idiopathic-isolated focal dystonia

By Lehn Alexander   Mellick George   Boyle Richard  

Journal of Neurology, Vol. 261, Iss. 4, 2014-04 ,pp. : 668-674

Springer Publishing Company

Access to resources Recommend Favorite